Compare · ACCD vs HLXA
ACCD vs HLXA
Side-by-side comparison of Accolade Inc. (ACCD) and Helix Acquisition Corp. (HLXA): market cap, price performance, sector, and recent activity on the wire.
Summary
- ACCD operates in Consumer Discretionary, while HLXA operates in Finance - the two are in different parts of the market.
- ACCD is the larger of the two at $1.18B, about 8.0x HLXA ($146.3M).
- ACCD has more recent analyst coverage (25 ratings vs 0 for HLXA).
- Company
- Accolade Inc.
- Helix Acquisition Corp.
- Price
- $7.03+0.00%
- $13.32+11.19%
- Market cap
- $1.18B
- $146.3M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Business Services
- Business Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2020
- News (4w)
- 0
- 0
- Recent ratings
- 25
- 0
Accolade Inc.
Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Helix Acquisition Corp.
Helix Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Boston, Massachusetts.
Latest ACCD
- Defining Wellness Centers Names Bill Morrison Chief Financial Officer
- SEC Form 15-12G filed by Accolade Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Accolade Inc.
- SEC Form 25-NSE filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- Chief Executive Officer Singh Rajeev returned $10,429,525 worth of shares to the company (1,483,574 units at $7.03), closing all direct ownership in the company (SEC Form 4)
Latest HLXA
- Bright Peak Therapeutics Appoints John Schmid to its Board of Directors
- SEC Form S-1/A filed by Helix Acquisition Corp. (Amendment)
- SEC Form S-1/A filed by Helix Acquisition Corp. (Amendment)
- Helix Acquisition Corp. filed SEC Form 8-K: Changes in Registrant’s Certifying Accountant, Financial Statements and Exhibits
- Helix Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Helix Acquisition Corp. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits (Amendment)
- SEC Form 10-Q filed by Helix Acquisition Corp.
- SEC Form 4 filed by Sturge Simon
- SEC Form 4 filed by Xavier Ramnik
- SEC Form 4 filed by Moukheibir Catherine